✦ LIBER ✦

25 Gefitinib in the treatment of non-small cell lung cancer (NSCLC) patients with EGFR-TK mutation – North Trent Cancer Network experience

✍ Scribed by Nugent, L.; Das, T.; Mohanamurali, J.; Danson, S.J.; Fisher, P.M.; Hatton, M.Q.; Lee, C.E.; Woll, P.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN37 A Pharmacoeconomic Analysis of the

✍ J. Culig; M. Leppée; N. Skaron-Jakobovic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

19 A single centre experience of gefitin

✍ Walter, H.S.; Fennell, D.A.; Ahmed, S.I. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Gefitinib in the treatment of elderly pa

✍ Bearz, Alessandra; Fratino, Lucia; Spazzapan, Simon; Berretta, Massimiliano; Gia 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 103 KB

43 Use of first line maintenance chemoth

✍ Stansfield, R.; Mohanamurali, J.; Danson, S.J.; Fisher, P.M.; Hatton, M.Q.; Lee, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Impact of physical size on gefitinib eff

✍ Ichihara, Eiki; Hotta, Katsuyuki; Takigawa, Nagio; Kudo, Kenichiro; Kato, Yuka; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 587 KB

Usefulness of cumulative smoking dose fo

✍ Masaru Jida; Shinichi Toyooka; Tetsuya Mitsudomi; Toshimi Takano; Keitaro Matsuo 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB